Skip to main content

Research-informed explainer · Last reviewed April 12, 2026

Hemodialysis vs peritoneal dialysis: which is right for you

Hemodialysis vs peritoneal dialysis compared: how each works, survival data, lifestyle trade-offs, and who each approach fits best.

Research-informed explainer — last updated April 12, 2026

When kidney function drops low enough that the kidneys can no longer filter waste and fluid on their own, dialysis becomes necessary to stay alive. There are two main options: hemodialysis, which filters blood through a machine usually at a clinic three times a week, and peritoneal dialysis, which uses the lining of the abdomen to filter waste continuously at home. Both can keep you alive and well for years, and for most patients with end-stage kidney disease, the research doesn't show a clear survival advantage for either one. What differs is how each fits into your life.

This explainer walks through how the two options work, what the evidence says about outcomes, and what factors most often drive the decision. It draws on research from nephrologists in the Convene directory with expertise in dialysis outcomes and kidney failure management, including specialists at Stanford, Brigham and Women's, and Cleveland Clinic.

What's the difference?

Hemodialysis (HD) circulates your blood through a dialysis machine that acts as an artificial kidney — removing waste products, excess salt, and fluid, then returning the cleaned blood to your body. Most patients receive three sessions per week at a dialysis center, each lasting about four hours. Some patients do HD at home, including nightly options that dialyze more frequently and gently. You need a vascular access point (usually a fistula in your arm, or a catheter) to connect to the machine.

Peritoneal dialysis (PD) uses the peritoneum — the membrane lining the inside of your abdominal cavity — as the filter. A catheter is placed in your abdomen, and dialysis fluid is infused and later drained through it. Waste and excess fluid pass from blood vessels in the peritoneal membrane into the fluid, which is then drained away. Most people do PD at home using one of two schedules: CAPD (continuous ambulatory PD), where you manually exchange fluid several times a day, or CCPD (automated PD), where a machine cycles the fluid overnight while you sleep. You perform the exchanges yourself, which requires training but offers considerable flexibility.

At a glance

Hemodialysis (HD)Peritoneal dialysis (PD)
Where it's doneDialysis center (or home for home HD)At home
Frequency3x per week (4 hours each)Daily (overnight automated, or multiple manual exchanges)
Access requiredVascular access (fistula or catheter)Abdominal catheter
Survival differenceSimilar to PD for most patientsSimilar to HD for most patients
Main risksAccess infections, cardiovascular stress, scheduling constraintsPeritonitis, catheter issues, technique failure
Who it tends to suitPatients who prefer clinical supervision; those with less residual kidney functionPatients who want flexibility and independence; those with some residual function

What the research shows about survival

The long-running debate over whether HD or PD leads to better survival has not produced a clear winner. Large observational studies from the United States Renal Data System and international registries have generally found comparable outcomes across the two modalities when patients are matched for age, comorbidities, and disease characteristics.

The picture is more nuanced when you look at subgroups. Patients with significant residual kidney function (patients who start dialysis with their kidneys still contributing something) tend to preserve that residual function longer on PD than on HD. This matters because residual renal function — even partial — is independently associated with better survival and fewer hospitalizations. Patients who are younger and healthier at the time of dialysis initiation also tend to do well on PD.

Understanding why CKD progresses to the point of requiring dialysis is essential context for these decisions. A landmark analysis of more than 1.1 million patients in the Kaiser Permanente system found a graded, independent association between declining estimated GFR and higher rates of death, cardiovascular events, and hospitalization — establishing that CKD progression carries real risks at every stage, not just at end-stage disease [1].

Hemodialysis: what happens during treatment

The three-times-weekly HD schedule means most patients spend roughly 12 hours per week at a dialysis center. Sessions remove the fluid and waste that accumulates between treatments. Because this happens in large batches rather than continuously, there can be significant fluctuations in blood pressure and fluid balance — particularly at the beginning of treatment when fluid removal is rapid. These cardiovascular swings are one of the most important challenges of in-center HD.

Mineral metabolism is a major concern in maintenance HD. An analysis of 40,538 hemodialysis patients found that hyperphosphatemia — elevated serum phosphorus, which builds up because the kidneys are no longer filtering it out — was independently associated with higher all-cause mortality and cardiovascular death [2]. Managing phosphorus requires strict dietary phosphate restriction and phosphate-binding medications. Sevelamer, a non-calcium-based phosphate binder, was shown in a randomized trial to slow the progression of coronary and aortic calcification in hemodialysis patients compared with calcium-based binders [4].

Home hemodialysis is a less common but growing option. Nightly home HD — performed five to six nights per week for shorter sessions — provides more continuous filtration and is associated with better blood pressure control and phosphorus management than conventional three-times-weekly center HD.

Peritoneal dialysis: what daily life looks like

The practical reality of PD is continuous engagement with a medical process. CAPD requires four to five exchanges a day, each taking about 30 minutes. CCPD uses a cycler machine at night, which offers more freedom during waking hours — most patients attach to the machine at bedtime and disconnect in the morning. Either way, managing supplies, catheter hygiene, and exchange technique becomes part of daily life.

The most serious complication is peritonitis — infection of the peritoneal cavity. Peritonitis can be severe, and repeated episodes can damage the peritoneal membrane, eventually making PD no longer viable. Technique and hygiene are critical: PD patients receive extensive training, and infection rates have fallen substantially as training protocols and disconnect systems have improved.

For patients who travel for work or prefer to manage their own care, PD's independence from a clinic schedule is a real advantage. Connecting to a machine at home overnight is very different from planning your week around three clinic sessions.

Transplantation as the longer-term goal

For eligible patients, kidney transplantation offers better outcomes than either form of dialysis. Dialysis — whether HD or PD — is typically a bridge rather than a permanent solution. A review published in the Cleveland Clinic Journal of Medicine outlines the key challenges and opportunities in kidney transplantation, including the persistent gap between organ availability and patient need [7]. Long-term graft survival has improved substantially over recent decades, though maintaining that function long-term remains an area of active research [6].

Both HD and PD patients can be transplanted, and the choice of dialysis modality during the wait period does not typically preclude transplant. Some data suggest PD patients may have marginally better immediate post-transplant outcomes, possibly related to better preservation of residual renal function — though this is not uniformly established.

How to make the decision

The choice between HD and PD depends on a combination of medical factors and personal preference:

Medical considerations: Significant abdominal scarring from prior surgeries can make PD catheter placement difficult or impossible. Certain hernias or structural issues also limit PD. Patients with very low residual kidney function or those starting dialysis urgently often begin on HD. Cardiovascular instability that makes HD's intermittent fluid removal poorly tolerated can favor PD.

Lifestyle and practical factors: Do you live alone and prefer clinical supervision? HD centers provide built-in monitoring. Do you travel frequently or work nonstandard hours? PD gives you more scheduling control. Are you comfortable managing a medical procedure yourself at home? PD requires self-discipline and consistent technique. Are there caregivers who can help? Both home HD and PD can involve family members in the process.

Timing: Starting the conversation early — before you reach dialysis urgency — gives you time to plan, get a catheter placed electively, and train at your own pace. Emergency dialysis starts are more likely to land in HD because the setup is immediate, but choosing HD under those circumstances isn't necessarily the right long-term fit.

Questions to ask your doctor

  • Given my specific medical history and anatomy, are there reasons I might not be a candidate for PD?
  • How much residual kidney function do I have, and does that change which option is better for me right now?
  • What does a typical week look like on each modality, and which is more compatible with my work and family situation?
  • If I start on HD, can I switch to PD later — and vice versa?
  • Am I a candidate for kidney transplantation, and how does my choice of dialysis affect the path to transplant?
  • What happens if I develop peritonitis or have technical problems with PD? What's the fallback?

The bottom line

For most patients with end-stage kidney disease, hemodialysis and peritoneal dialysis produce similar survival outcomes. The right choice depends on your medical anatomy, your remaining kidney function, your living situation, and how much control you want over your own care. Neither option is automatically superior — both require commitment, and both carry real risks. The decision is best made early, ideally before dialysis is urgent, in conversation with a nephrologist who knows your specific situation. Transplantation remains the long-term goal for eligible patients, and dialysis — whichever form you choose — is the bridge to get there.

Research informing this article

Peer-reviewed research from the following specialists listed on Convene informs this explainer. They did not write or review the article; their published work is cited throughout.

  • Glenn Chertow, MD

    Norman S. Coplon/Satellite Healthcare Professor of Medicine; Chief, Division of Nephrology; Professor, by courtesy, of Epidemiology and Population Health and of Health Policy; Associate Chair, Department of Medicine

    Stanford Health Care

  • Dirk Hentschel, MD

    Director Interventional Nephrology, Brigham and Women's Hospital

    Brigham and Women's Hospital

  • Joshua Augustine, MD

    Associate Professor, Medicine, Case Western Reserve University School of Medicine

    Cleveland Clinic (9500 Euclid Avenue, Cleveland, OH 44195)

Sources

  1. 1.
    Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004. DOI
  2. 2.
    Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004. DOI
  3. 3.
    Intensity of Renal Support in Critically Ill Patients with Acute Kidney InjuryNew England Journal of Medicine, 2008. DOI
  4. 4.
    Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney International, 2002. DOI
  5. 5.
    A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARFAmerican Journal of Kidney Diseases, 2004. DOI
  6. 6.
    Long-term kidney transplant graft survival—Making progress when most neededAmerican Journal of Transplantation, 2020. DOI
  7. 7.
    Kidney transplant: New opportunities and challengesCleveland Clinic Journal of Medicine, 2018. DOI
  8. 8.
    High-resolution quantitative imaging of mammalian and bacterial cells using stable isotope mass spectrometryJournal of Biology, 2006. DOI

Related articles